Parallax Volatility Advisers, L.P. Iovance Biotherapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $39,524 - $106,475	11,977 New	11,977 $97,000
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $35,178 - $64,527	1,227 Added 126.63%	2,196 $70,000
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $27,170 - $48,701	969 New	969 $45,000
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $256,425 - $459,627	-9,145 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$27.75 - $36.3 $253,773 - $331,963	9,145 New	9,145 $301,000
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $51,526 - $102,447	-2,637 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $47,154 - $77,260	2,627 Added 26270.0%	2,637 $73,000
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $97 - $245	10 New	10 $0
Q1 2019 May 15, 2019	SELL	$8.41 - $11.26 $1,463 - $1,959	-174 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $50,399 - $80,062	-6,711 Reduced 97.47%	174 $2,000
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $77,456 - $121,864	6,885 New	6,885 $77,000
Q1 2018 May 15, 2018	SELL	$8.1 - $19.5 $76,204 - $183,456	-9,408 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$6.65 - $9.25 $62,563 - $87,024	9,408	9,408 $75,000

319

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $945M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.